FDA finishes its review of a Medifocus Prolieve post-approval study that the company says confirms the treatments long-term safety, efficacy, and dura...
FDA clears an EOS Imaging 510(k) for its hipEOS 3.0 surgical planning software.
FDA clears a Royal Philips 510(k) for the Ingenia Elition 3.0T magnetic resonance (MR) device and two clinical applications, Philips Compressed SENSE ...
FDA commissioner Scott Gottlieb says the agency is taking steps to make the drug development continuum more efficient and cost-effective.
FDA warns Creative Science it is marketing an unapproved new animal drug.
FDA clears Spineology 510(k) for its Rampart One Standard ALIF interbody fusion system for use with or without supplemental fixation.
FDA approves Mylans Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Amgens Neulasta (pegfilgrastim) to decrease the chance of infection as su...
Federal Register notice: FDA issues a proposed order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast les...